• DAVYCA-F

    [pdf-embedder url="https://davipharm.info/wp-content/uploads/DAVYCA_F.pdf"]
  • DAVYCA

    [pdf-embedder url="https://davipharm.info/wp-content/uploads/DAVYCA_07.pdf"]
  • VALMAGOL

    Magnesi valproat is indicated for: - Epilepsy - Treatment of manic episodes associated with bipolar disorder This is only the preview. Please check here for…
  • ZAPNEX-10

    Treatment of schizophrenia. Maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response. Treatment of moderate to severe manic…
  • WAZER

    Major depressive episodes. Panic disorder. Obsessive-compulsive disorder. This is only the preview. Please check here for the full indication.
  • SULLIVAN

    Amisulprid is indicated for the treatment of acute and chronic schizophrenic disorders in which positive symptoms (such as delusions, hallucinations and thought disorders) and/or negative…
  • STOGURAD

    Short term symptomatic treatment of anxiety in adults with failure standard treatments. Severe behavioral disorder in children (agitation, self-amputation, stereotypy), especially in the context of…
  • SHAKES

    Treatment of episodes of major depression. This is only the preview. Please check here for the full indication.
  • SERNAL-4

    The acute and maintenance treatment of schizophrenia (both negative and positive symptoms). When deciding to use long-term risperidon, it should periodically re-evaluate the effectiveness of…
  • QUEITOZ-100

    Quetiapine is indicated for: • Treatment of schizophrenia. • Treatment of bipolar disorder: - For the treatment of moderate to severe manic episodes in bipolar…
  • CERAHEAD-F

    Symptomatic treatment of vertigo. Elderly suffering from loss of memory, vertigo, lack of concentration or alertness, changes of mood, deterioration in behaviour, personal negligence, dementia…
  • ZAPNEX-5

    Treatment of schizophrenia. Maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response. Treatment of moderate to severe manic…
  • SERNAL

    The acute and maintenance treatment of schizophrenia (both negative and positive symptoms). When deciding to use long-term risperidon, it should periodically re-evaluate the effectiveness of…
  • NILKEY

    Acute and maintenance treatment of Major Depressive Disorder. Acute and maintenance treatment of obsessions and compulsions in patients with Obsessive Compulsive Disorder (OCD). Acute and…
  • MANZURA-7.5

    Treatment of schizophrenia. Maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response. Treatment of moderate to severe manic…
  • MANZURA-5

    Treatment of schizophrenia. Maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response. Treatment of moderate to severe manic…
  • MANZURA-15

    Treatment of schizophrenia. Maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response. Treatment of moderate to severe manic…
  • LEVETRAL-750

    Monotherapy in the treatment of partial onset seizures with or without secondary generalisation in adults and adolescents from 16 years of age with newly diagnosed…
  • LEVETRAL

    Monotherapy in the treatment of partial onset seizures with or without secondary generalisation in adults and adolescents from 16 years of age with newly diagnosed…
  • KEIKAI

    Monotherapy for the short-term treatment of primary insomnia characterised by poor quality of sleep in patients who are aged 55 or over. This is only…
  • KAUSKAS-50

    Epilepsy Adults and adolescents aged 13 years and above - Adjunctive or monotherapy treatment of partial seizures and generalised seizures, including tonic-clonic seizures. - Seizures…
  • KAUSKAS-200

    Epilepsy Adults and adolescents aged 13 years and above - Adjunctive or monotherapy treatment of partial seizures and generalised seizures, including tonic-clonic seizures. - Seizures…